IL-1 receptor antagonist gene polymorphism in patients with secondary acute myeloid leukaemia

Cytokines, Cellular and Molecular Therapy

Volumn 4, Issue 1, 1998, Pages 7-9

  Langabeer, Stephen E ^a   Linch, David C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

AML; Genetic association; IL 1ra; Polymorphism

Indexed keywords

DNA; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; DISEASE SEVERITY; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MYELODYSPLASIA; PATHOGENESIS; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT;

ACUTE DISEASE; AGE FACTORS; GENE FREQUENCY; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LEUKEMIA, MYELOID; MYELODYSPLASTIC SYNDROMES; POLYMORPHISM, GENETIC; SIALOGLYCOPROTEINS;

EID: 0031921858     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Culligan D, Jacobs A, Padua RA, The genetic basis of myelodysplasia. In: Recent Advances in Haematology 7 (ed MK Brenner, AV Hoffbrand) 35-53 Churchill Livingstone, London, 1993.
2. Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip P, Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood (1995) 86: 3542-52.
3. Smith MA, McCaffrey RP, Karp JE, The secondary leukemias: challenges and research directions. J Natl Cancer Inst. (1996) 88: 407-18.
4. Detourmignies L, Castaigne S, Stoppa AM et al, Therapy-related acute promyelocytic leukemia: a report on 16 cases. J Clin Oncol (1992) 10: 1430-25.
5. Dinarello CA, Biological basis for interleukin-1 in disease. Blood (1996) 87: 2095-147.
6. Estrov Z, Kurzrock R, Talpaz M, Role of interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leukemia. Leuk Lymphoma (1993) 10: 407-18.
7. Mansfield C, Holden H, Tarlow JK et al, Novel generic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology (1994) 106: 637-42.
8. Blakemore AIF, Watson PF, Weetman AP, Duff GW, Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab (1995) 80: 111-15.
9. Demeter J, Messer G, Ramisch S et al, Polymorphism within the second intron of the IL-1 receptor antagonist gene in patients with haematopoietic malignancies. Cytokines Mol Ther (1996) 2: 239-42.
10. Tarlow JK, Blakemore AIF, Lennard A et al, Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86 bp tandem repeat. Hum Genet (1993) 91: 403-4.
11. Danis VA, Millington M, Hyland VJ, Grennan D, Cytokine production by normal human monocytes: intersubject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol (1995) 99: 303-10.